Synexus US retweeted
Throughout #RSVAwarenessMonth, we are raising awareness of respiratory syncytial virus or #RSV, which can be difficult to distinguish from the flu or other respiratory infections. Sarah thought her symptoms were due to her #COPD, but it was something more.
Synexus US retweeted
We are delighted to be attending the 3rd Annual NASH-TAG Conference 2019 in Park City, Utah, US. To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]
#NashTagConf
Synexus US retweeted
We are looking forward to attending the CNS Summit 2018 in Boca Raton, Florida, U.S. from 1-4 November.
To discuss how the Synexus model provides an unrivalled capacity to deliver the right patients at the right time for the right trial, please email: [email protected]
Synexus US retweeted
Vascular diseases account for 40% of deaths in the UK*.
Today we are recognising Vascular Disease Awareness Month in the UK and our commitment in continuing to support cardiology studies.
Together we make a difference. https://nitter.cf/t.co/ASmFEQhPJF
*Source: https://nitter.cf/t.co/CWJWpVDALM
Synexus US retweeted
Synexus is excited about our collaboration with University of Exeter to launch the Synexus HealthyMinds, US- based registry. The goal is to register 30,000 adults in the US to help understand how healthy brains age.
View the full article here: https://nitter.cf/t.co/egnG0O77cg
Synexus US retweeted
Really excited about our new collaboration with @SynexusUS to establish the Synexus HealthyMinds Registry. Initial aim is to sign up 30,000 ppl to take part in trials to protect #brainhealth – huge recruitment boost in #dementia prevention trials! #ExeterDementia #AAIC2018 nitter.cf/ExeterMed/status/10214…
Excited to announce our collaboration with @SynexusResearch, who'll be launching one of the largest research initiatives in the United States to help understand how healthy brains age.
Read more here: https://nitter.cf/t.co/Brxlq8VDqT #ExeterDementia @SynexusUS
Synexus US retweeted
Synexus is proud to announce a collaboration to launch one of the largest, registry-based research initiatives in the United States to help understand how healthy brains age.
View the full article here: https://nitter.cf/t.co/egnG0O77cg
Synexus US retweeted
Come & see us at Booth #2115 at DIA 2018 in Boston, Massachusetts, 24–28 June, where we’ll be introducing SynexusPlus, the new standard in clinical trial productivity.
To discover how SynexusPlus can optimise productivity & efficiency, Visit synexus.com/dia-2018/
#DIA2018
Synexus US retweeted
We are looking forward to attending ATS 2018 at the International Conference Centre, San Diego, 18-23 May. To discuss how the Synexus model can effectively facilitate the advancement of medicine please email: [email protected]
Synexus US retweeted
We’re recognising World Immunisation Week.
We regularly conduct research studies for vaccines for the prevention of many diseases.
Together we can make a difference
Find out more about the world’s leading site network organisation #VaccinesWork
synexus.com/
Synexus US retweeted
We are delighted to be attending the World Vaccine Congress at Renaissance Washington DC Downtown Hotel, 2-5 April 2018. To discuss how the Synexus model can effectively facilitate the future of vaccine research and development please email: [email protected].
Synexus US retweeted
Synexus are delighted to be sponsoring the 2018 European Site Solutions Summit at The Tower Hotel in London on 26-27 March 2018.
If you would like to engage or network with key figures in our industry and meet our team, please email: [email protected] #SCRS18EU
Synexus US retweeted
Our Managing Director for Central & Eastern Europe, Wojciech Szczepanik, PhD, MBA, MSc, will be facilitating a discussion on EU General Data Protection Regulation: What It Means for Your Site at 2.15pm during the event’s Breakout Session I in the Learning Lab. #SCRS18EU
Synexus US retweeted
The main benefit of diagnosing Mild Cognitive Impairment (MCI) is that it helps to identify people who are at increased risk of developing dementia*.
Find out more about the word's leading SMO: synexus.com #BrainWeek #BrainAwarenessWeek
Synexus US retweeted
Mild Cognitive Impairment (MCI) is a condition in which someone has minor problems with cognition - their mental abilities such as memory or thinking*.
Find out more about the word's leading SMO: synexus.com #BrainWeek #BrainAwarenessWeek
Synexus US retweeted
Today we're recognising World Kidney Day and our commitment to advancing medicine.
Together we can make a difference.
Find out more about the word's leading site network organisation: synexus.com #WorldKidneyDay #WKD
Synexus US retweeted
It’s simple: Love Your Heart, Love Your Brain. spr.ly/6013DRGkl
Synexus US retweeted
Come meet the Synexus team at #scope2018 today. We're at booth #414!
Synexus US retweeted
We’re recognising National Heart Month and our commitment to advancing medicine.
Together we can make a difference.
Find out more about the world’s leading site network organisation at buff.ly/2GuglaO
#NationalHeartMonth
























